Protein expression has become an increasingly important part of the biotechnology value chain as pharmaceutical and biotechnology companies expand their focus on recombinant proteins, monoclonal antibodies, biosimilars, vaccines, and personalized therapies. Improvements in expression systems are helping researchers produce complex proteins with greater efficiency while supporting faster drug...